Caitong International Asset Management Co., Ltd
Position in ZYBT — Zhengye Biotechnology Holding Ltd
CIK 1963355
HONG KONG, K3
Position in ZYBT
as of Jun 30, 2026
· filed Aug 5, 2026
Position Value
$1
+$0 QoQ
Shares Held
1
0.0% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#8
of 8 holders
Holding Since
Sep 2025
4 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in ZYBT Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Jun 30, 2026Caitong International Asset Management Co., Ltd holds $770,442 across 41 Drug Manufacturers - Specialty & Generic names. ZYBT ranks #36 (0.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | BCRX |
Biocryst Pharmaceuticals Inc
|
20,925 | $209,250 | |
| 2 | RDY |
Dr Reddys Laboratories Ltd
|
11,751 | $170,271 | |
| 3 | TAK |
Takeda Pharmaceutical Co Ltd
|
6,656 | $106,695 | |
| 4 | TEVA |
Teva Pharmaceutical Industries Ltd
|
2,099 | $71,114 | |
| 5 | SUPN |
Supernus Pharmaceuticals, Inc.
|
973 | $45,254 | |
| 6 | ETON |
Eton Pharmaceuticals, Inc.
|
842 | $30,480 | |
| 7 | LQDA |
Liquidia Corp
|
331 | $26,390 | |
| 8 | XERS |
Xeris Biopharma Holdings, Inc.
|
2,746 | $21,748 |
All Filings in ZYBT
Export CSV
4 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $1 | 1 | Shares | Sole | 2026-08-05 | |
| 2026-03-31 | $1 | 1 | Shares | Sole | 2026-05-11 | |
| 2025-12-31 | $1 | 1 | Shares | Sole | 2026-03-04 | |
| 2025-09-30 | $2 | 1 | Shares | Sole | 2025-11-19 | |
| No filing history on record for this holder in this stock. | ||||||